An Urban Community's Preferences for Hypothetical Outcomes of Analgesic Pain Treatment

Journal of Pain and Symptom Management

Volumn 32, Issue 5, 2006, Pages 470-477

  Palos, Guadalupe R ^a   Cantor, Scott B ^a   Aday, Lu Ann ^a   Mendoza, Tito R ^a   Mobley, Gary M ^a   Cleeland, Charles S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

community preferences; Pain management; treatment outcomes; utilities

Indexed keywords

ANALGESIC AGENT;

ADULT; ANALGESIA; ARTICLE; CANCER PAIN; CONFUSION; CONSTIPATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT COMPLIANCE; PREDICTION; RATING SCALE; SOMNOLENCE; TELEPHONE; TREATMENT OUTCOME; URBAN POPULATION; VOMITING; XEROSTOMIA;

ADULT; ANALGESICS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PAIN; PATIENT SATISFACTION; TREATMENT OUTCOME; URBAN POPULATION;

EID: 33750532982     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2006.05.022     Document Type: Article

References (28)

1. Daut R.L., and Cleeland C.S. The prevalence and severity of pain in cancer. Cancer 50 9 (1982) 1913-1918
2. Foley K.M. Controlling cancer pain. Hosp Pract (Off Ed) 35 4 (2000) 101-102
3. Hanks G.W., Conno F., Cherny N., et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84 5 (2001) 587-593
4. Jacox A., Carr D.B., Payne R., et al. Clinical practice guideline No. 9: Management of cancer pain (1994), Agency for Health Care Policy and Research, US Department of Health and Human Services, Rockville, MD AHCPR publication 94-0592
5. Anderson K.O., Richman S.P., Hurley J., et al. Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer 94 8 (2002) 2295-2304
6. Miaskowski C., Dodd M.J., West C., et al. Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol 19 23 (2001) 4275-4279
7. Ward S.E., Berry P.E., and Misiewicz H. Concerns about analgesics among patients and family caregivers in a hospice setting. Res Nurs Health 19 3 (1996) 205-211
8. Bostrom M. Summary of the Mayday Fund Survey: public attitudes about pain and analgesics. J Pain Symptom Manage 13 3 (1997) 166-168
9. Levin D.N., Cleeland C.S., and Dar R. Public attitudes toward cancer pain. Cancer 56 9 (1985) 2337-2339
10. Palos G.R., Mendoza T.R., Cantor S.B., Aday L.A., and Cleeland C.S. Perceptions of analgesic use and side effects: what the public values in pain management. J Pain Symptom Manage 28 5 (2004) 460-473
11. Cherny N., Ripamonti C., Pereira J., et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19 9 (2001) 2542-2554
12. Froberg D.G., and Kane R.L. Methodology for measuring health-state preferences-I: measurement strategies. J Clin Epidemiol 42 4 (1989) 345-354
13. SPSS statistical software program for windows, Vol. 12.0 (2003), SPSS Inc., Chicago, IL
14. Paice J.A., Toy C., and Shott S. Barriers to cancer pain relief: fear of tolerance and addiction. J Pain Symptom Manage 16 1 (1998) 1-9
15. Ward S.E., Goldberg N., Miller-McCauley V., et al. Patient-related barriers to management of cancer pain. Pain 52 3 (1993) 319-324
16. Ward S.E., and Hernandez L. Patient-related barriers to management of cancer pain in Puerto Rico. Pain 58 2 (1994) 233-238
17. Ziegler D.K., Mosier M.C., Buenaver M., and Okuyemi K. How much information about adverse effects of medication do patients want from physicians?. Arch Intern Med 161 5 (2001) 706-713
18. Essink-Bot M.L., Bonsel G.J., and van der Maas P.J. Valuation of health states by the general public: feasibility of a standardized measurement procedure. Soc Sci Med 31 11 (1990) 1201-1206
19. Stiggelbout A.M., and de Haes J.C. Patient preference for cancer therapy: an overview of measurement approaches. J Clin Oncol 19 1 (2001) 220-230
20. Gold M.R. Cost-effectiveness in health and medicine (1996), Oxford University Press, New York
21. Patrick D.L., Pearlman R.A., Starks H.E., et al. Validation of preferences for life-sustaining treatment: implications for advance care planning. Ann Intern Med 127 7 (1997) 509-517
22. Dolan P., and Kind P. Inconsistency and health state valuations. Soc Sci Med 42 4 (1996) 609-615
23. Jansen S.J., Kievit J., Nooij M.A., and Stiggelbout A.M. Stability of patients' preferences for chemotherapy: the impact of experience. Med Decis Making 21 4 (2001) 295-306
24. Kind P., and Dolan P. The effect of past and present illness experience on the valuations of health states. Med Care 33 4 Suppl (1995) AS255-AS263
25. Badia X., Herdman M., and Kind P. The influence of ill-health experience on the valuation of health. Pharmacoeconomics 13 6 (1998) 687-696
26. Devlin N.J., Hansen P., Kind P., and Williams A. Logical inconsistencies in survey respondents' health state valuations: a methodological challenge for estimating social tariffs. Health Econ 12 7 (2003) 529-544
27. Dolan P. The effect of experience of illness on health state valuations. J Clin Epidemiol 49 5 (1996) 551-564
28. Llewellyn-Thomas H., Sutherland H.J., Tibshirani R., et al. Describing health states. Methodologic issues in obtaining values for health states. Med Care 22 6 (1984) 543-552